Literature DB >> 8006119

Unusual cranial aspects of the Apert syndrome.

M M Cohen1, S Kreiborg.   

Abstract

Frank cloverleaf skull is found in approximately 4% of Apert-syndrome infants. However, the usual Apert skull and its cloverleaf form are spectral in nature. In all patients, the temporal bones are obliquely situated, and the degree to which this is so determines whether no, mild, moderate, or severe cloverleafing will occur. True encephalocele rarely is found in the Apert syndrome, but pseudoencephalocele in the frontal region sometimes is confused with it. Because the Apert calvaria at birth is characterized by a widely gaping midline defect, the midfrontal region of the brain is not covered by bone during early infancy. However, with time, closure of the midline defect occurs by coalescence of bony islands, thus covering the pseudoencephalic region. Also discussed in this paper are (a) atypical calvarial development with patency of the coronal sutures in one case, (b) size and position of the temporal muscles, and (c) size and position of the superficial temporal fat pads.

Entities:  

Mesh:

Year:  1994        PMID: 8006119

Source DB:  PubMed          Journal:  J Craniofac Genet Dev Biol        ISSN: 0270-4145


  3 in total

1.  Central nervous system and cervical spine abnormalities in Apert syndrome.

Authors:  Omar Breik; Antony Mahindu; Mark H Moore; Cindy J Molloy; Stephen Santoreneos; David J David
Journal:  Childs Nerv Syst       Date:  2016-02-10       Impact factor: 1.475

2.  A genomewide linkage scan for quantitative trait loci influencing the craniofacial complex in baboons (Papio hamadryas spp.).

Authors:  Richard J Sherwood; Dana L Duren; Lorena M Havill; Jeff Rogers; Laura A Cox; Bradford Towne; Michael C Mahaney
Journal:  Genetics       Date:  2008-08-30       Impact factor: 4.562

3.  Unilateral Coronal Craniosynostosis in an Apert-Like Patient.

Authors:  Navid Pourtaheri; Derek Z Wang; Robert P Lesko; Christopher M Bonfield; Peter Taub; Anand R Kumar
Journal:  Plast Surg (Oakv)       Date:  2018-10-03       Impact factor: 0.947

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.